ACP
ABBV icon

Aveo Capital Partners’s AbbVie ABBV Stock Holding History

Aveo Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,679
Closed -$476K – 178
2024
Q4 		$476K Sell
2,679
-42
-2% -$7.72K 0.05% 215
2024
Q3 		$537K Sell
2,721
-526
-16% -$98.2K 0.06% 190
2024
Q2 		$557K Sell
3,247
-993
-23% -$164K 0.06% 177
2024
Q1 		$695K Sell
4,240
-57
-1% -$9.82K 0.08% 177
2023
Q4 		$666K Buy
4,297
+210
+5% +$30.6K 0.08% 172
2023
Q3 		$609K Buy
4,087
+150
+4% +$22K 0.08% 176
2023
Q2 		$530K Sell
3,937
-74
-2% -$10.9K 0.07% 196
2023
Q1 		$639K Buy
4,011
+1,712
+74% +$262K 0.09% 160
2022
Q4 		$371K Buy
2,299
+96
+4% +$14.7K 0.06% 234
2022
Q3 		$296K Sell
2,203
-243
-10% -$34.9K 0.05% 215
2022
Q2 		$375K Sell
2,446
-47
-2% -$7.18K 0.06% 202
2022
Q1 		$404K Sell
2,493
-1,345
-35% -$195K 0.07% 198
2021
Q4 		$520K Buy
3,838
+326
+9% +$38.5K 0.09% 170
2021
Q3 		$379K Buy
3,512
+76
+2% +$8.68K 0.08% 183
2021
Q2 		$387K Buy
3,436
+19
+0.6% +$2.14K 0.09% 185
2021
Q1 		$370K Buy
+3,417
New +$365K 0.09% 167
2019
Q4 		– Sell
-2,583
Closed -$214K – 189
2019
Q3 		$214K Buy
+2,583
New +$177K 0.09% 167
2019
Q1 		– Sell
-2,465
Closed -$227K – 168
2018
Q4 		$227K Buy
+2,465
New +$217K 0.11% 116
2018
Q3 		– Sell
-2,523
Closed -$234K – 141
2018
Q2 		$234K Buy
2,523
+179
+8% +$17.5K 0.1% 121
2018
Q1 		$222K Sell
2,344
-232
-9% -$25.5K 0.09% 125
2017
Q4 		$249K Sell
2,576
-148
-5% -$13.9K 0.08% 118
2017
Q3 		$242K Sell
2,724
-35
-1% -$2.66K 0.08% 109
2017
Q2 		$200K Buy
+2,759
New +$185K 0.07% 126
2017
Q1 		– Sell
-4,991
Closed -$313K – 130
2016
Q4 		$313K Buy
+4,991
New +$305K 0.09% 141

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Aveo Capital Partners's ABBV Position: Q1 2025 in Review

Aveo Capital Partners sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 2,679 shares — an estimated $476K sold.

Aveo Capital Partners first reported a position in ABBV in Q4 2016 and held it in 24 quarters. The position peaked at $695K in Q1 2024. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Aveo Capital Partners reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Aveo Capital Partners sold 2,679 AbbVie shares in Q1 2025, an estimated $476K.
  • Aveo Capital Partners first reported a position in AbbVie in Q4 2016 and held it in 24 quarters.
  • Aveo Capital Partners's AbbVie position peaked at $695K in Q1 2024.
  • 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Aveo Capital Partners's 13F filing for Q1 2025, filed 12 May 2025.